Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current status of biodegradable stents

J F Tanguay1, J P Zidar, H R Phillips

  • 1Interventional Cardiovascular Program, Duke University Medical Center, Durham, North Carolina.

Cardiology Clinics
|November 1, 1994
PubMed
Summary

Metallic stents have limitations for coronary angioplasty, prompting interest in biodegradable stents. These novel devices offer a scaffold and sustained drug delivery to prevent restenosis and acute closure post-PTCA.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sternal neoangiogenesis following internal mammary artery devascularization: an experimental model.

The Journal of cardiovascular surgery·2012
Same author

Intravascular stents.

Trends in cardiovascular medicine·2011
Same author

Adjuvant radiation therapy for low stage testicular seminoma: Diagnosis and therapy in evolution.

Urologic oncology·2011
Same author

THE USE OF PARALDEHYDE BEFORE ANAESTHESIA.

British medical journal·2010
Same author

Apparatus for Administering Oxygen with Ether and Chloroform.

Proceedings of the Royal Society of Medicine·2009
Same author

Conscious and anesthetized non-human primate safety pharmacology models: hemodynamic sensitivity comparison.

Journal of pharmacological and toxicological methods·2008

Area of Science:

  • Cardiovascular medicine
  • Biomaterials science
  • Interventional cardiology

Background:

  • Coronary angioplasty (PTCA) is limited by abrupt closure and restenosis.
  • Metallic stents improve outcomes but are permanent, limiting drug delivery and long-term vessel remodeling.
  • Current drug delivery catheters face challenges with efficiency and retention.

Purpose of the Study:

  • To address the limitations of metallic stents in coronary angioplasty.
  • To explore biodegradable stents as a scaffold and drug delivery vehicle.
  • To propose biodegradable stents for preventing post-PTCA restenosis and acute closure.

Main Methods:

  • Review of metallic stent limitations.
  • Analysis of initial animal studies on polymeric (biodegradable) stents.

Related Experiment Videos

  • Proposal of biodegradable stents for local drug delivery applications.

    • Main Results:

    • Metallic stents are effective but have drawbacks for long-term vessel health.
    • Biodegradable stents offer a potential solution for scaffold and sustained drug delivery.
    • Initial animal studies show promise for polymeric stents.

    Conclusions:

    • Biodegradable stents represent a promising alternative to metallic stents.
    • They can serve as a scaffold for vessel remodeling and a platform for sustained drug delivery.
    • Biodegradable stents may prevent restenosis and acute closure after PTCA.